跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 400 条关于
“CliniMACS”
全部
400
临床试验
358
药物
2
机构
14
资讯
26
2个月前
Point-of-Care CAR-T Manufacturing Achieves 15-Day Vein-to-Vein Time in Jordan Phase II Trial
10个月前
India Launches First CAR-T Manufacturing Training Program to Build Cell and Gene Therapy Expertise
去年
Miltenyi Biotec Launches India's First Cell & Gene Therapy Center of Excellence in Hyderabad
去年
Two Decades of NK Cell Trials Show Promise for AML Treatment with 37% Complete Remission Rate
去年
TRBC1-CAR T Cell Therapy Shows Promise in Peripheral T Cell Lymphoma
4年前
Dual-Targeting CAR-T Therapies Show Promise in Overcoming B-Cell Cancer Treatment Resistance
3年前
CAR-T Cell Therapy Shows Promise Despite Significant Safety Challenges in Clinical Trials
去年
Dual-Targeted CAR T-Cell Therapy Shows 100% Response Rate in Relapsed/Refractory Mantle Cell Lymphoma
去年
Regulatory Immune Cells Emerge as Key Therapeutic Targets in Immunotherapy and Autoimmune Disease Treatment
去年
Student-Run Dermatology Clinics Bridge Healthcare Gap for Underserved Communities
第 1 页,共 3 页
上一页
下一页